Monte Rosa Therapeutics, Inc. (GLUE) is a pioneering biopharmaceutical company based in Boston, Massachusetts, focused on developing precision small molecule therapeutics that leverage natural cellular processes for targeted protein degradation. The company employs its proprietary technology platforms to tackle substantial unmet medical needs, with a primary focus on oncology and autoimmune disorders, demonstrated through its robust pipeline of innovative drug candidates. Committed to scientific excellence and advancing treatment paradigms, Monte Rosa is well-positioned to enhance patient outcomes and lead transformative change in the pharmaceutical industry. Show more

Location: 321 HARRISON AVENUE, BOSTON, MA, UNITED STATES, 02118, Boston, MA, 02118, USA | Website: https://www.monterosatx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

1.565B

52 Wk Range

$3.50 - $25.77

Previous Close

$21.36

Open

$21.03

Volume

1,532,407

Day Range

$19.91 - $21.36

Enterprise Value

985.1M

Cash

208.3M

Avg Qtr Burn

N/A

Insider Ownership

0.81%

Institutional Own.

93.93%

Qtr Updated

09/30/25